--- title: "Zhitong Hong Kong Stock Shareholders' Equity Disclosure | October 1" type: "News" locale: "en" url: "https://longbridge.com/en/news/259613927.md" description: "According to the report from Zhitong Finance APP, LUNG KEE, MINTH GROUP, KB LAMINATES, Junshi Biosciences, and BONNY HLDG conducted their latest shareholder equity disclosures on October 1, 2025. Shao Yulong and Shao Tielong of LUNG KEE increased their holdings from 407 million shares to 414 million shares, with a slight decrease in shareholding ratio. Wei Qinglian of MINTH GROUP maintained her shareholding. Ye Shukun of KB LAMINATES reduced his holdings, while Li Xin of Junshi Biosciences significantly increased his holdings, and the shareholding of BONNY HLDG decreased from 37.39% to 0%" datetime: "2025-10-01T00:06:02.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/259613927.md) - [en](https://longbridge.com/en/news/259613927.md) - [zh-HK](https://longbridge.com/zh-HK/news/259613927.md) --- # Zhitong Hong Kong Stock Shareholders' Equity Disclosure | October 1 According to the Zhitong Finance APP, LUNG KEE (00255), MINTH GROUP (00425), KB LAMINATES (01888), Junshi Biosciences (01877), and BONNY HLDG (01906) disclosed their latest shareholder equity on October 1, 2025. Stock Name Institution Name Nature Shares Before Change Shares After Change Shareholding Ratio LUNG KEE (00255) Shao Yulong Good Position 407 million shares 414 million shares 65.52% (latest) 64.49% (previous) LUNG KEE (00255) Shao Tielong Good Position 407 million shares 414 million shares 65.52% (latest) 64.49% (previous) MINTH GROUP (00425) Wei Qinglian Good Position 451 million shares 451 million shares 38.35% (latest) 38.34% (previous) KB LAMINATES (01888) Ye Shukun Good Position 1.35 million shares 1.15 million shares 0.03% (latest) 0.04% (previous) Junshi Biosciences (01877) Li Xin Good Position 82,900 shares 1.2829 million shares 0.49% (latest) 0.04% (previous) BONNY HLDG (01906) Hong Kong Jun He Limited Good Position 550 million shares 0 shares 0% (latest) 37.39% (previous) Note: Changes in shareholding may be due to rights issues, consolidations, stock splits, etc. Please refer to the actual situation for identification ### Related Stocks - [00255.HK](https://longbridge.com/en/quote/00255.HK.md) - [00425.HK](https://longbridge.com/en/quote/00425.HK.md) - [01888.HK](https://longbridge.com/en/quote/01888.HK.md) - [01906.HK](https://longbridge.com/en/quote/01906.HK.md) - [688180.CN](https://longbridge.com/en/quote/688180.CN.md) - [01877.HK](https://longbridge.com/en/quote/01877.HK.md) ## Related News & Research - [Shanghai Junshi Biosciences Sets Board Meeting to Approve Q1 2026 Results](https://longbridge.com/en/news/282830459.md) - [STELLANTIS WEIGHS DONGFENG CARMAKING DEAL IN EUROPE, CHINA](https://longbridge.com/en/news/282832486.md) - [Keppel and Midea to collaborate on AI-enabled modular cooling solutions opportunities](https://longbridge.com/en/news/282548556.md) - [Junshi Biosciences schedules board meeting to review Q1 results](https://longbridge.com/en/news/282823588.md) - [RemeGen Drug Approved For Cancer Indication](https://longbridge.com/en/news/282478668.md)